Categories
Connect with us on LinkedIn
Clinical Trials Aren’t Just About Patients (and That’s Okay)
This article explores the debate between patient-centricity and protocol-centricity in clinical trials, featuring insights from Derk Arts (Castor)...
Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials
This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....
What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more
Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,...
2024: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
A New Perspective on Clinical Research: Accessibility and Innovation
Joost Rigter’s inspiring journey highlights the importance of accessibility in clinical research. From AI-driven tools to simplified communication,...
Local Labs in the EDC: Streamlining Safety and Efficacy Insights
Local labs are a vital part of clinical trials, offering fast, cost-effective insights into safety and efficacy. But...
Beyond Compliance: How Quality Culture Drives Clinical Trial Excellence
Moving beyond compliance, quality culture drives clinical trial innovation through automated processes and measurable results.
eCOA Evolution: Have We Overcomplicated What Used to Work?
A blueprint for engineering elegant eCOA solutions that make complex trials feel simple.
Waiver of Consent vs Waiver of Written Consent
One is very common, the other is rarely granted. Learn the key differences between waiver of consent &...
Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights
Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.
FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained
Watch back as our panel of experts discuss how the FDA views the collection of patient-reported outcomes for...
Understanding Phase 4 Clinical Trials: A Critical Component of Post-Marketing Insight to Drugs in the Real-World
When it comes to Phase 4 clinical trials, Castor's cutting-edge Real-World Evidence (RWE) platform is your key to...
Castor Launches “Castor for Impact Program” to Advance Health Equity in Clinical Research
Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech...
5 Key Takeaways from the FDA’s Real-World Evidence Guidance
A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance...
How MMI Leveraged Castor to Fulfill MDR Requirements for Their Groundbreaking Microsurgery Robot
Castor provided MMI with a compliant, user-friendly platform that was able to enhance enrollment by over 500% and...
Navigating the Evolving Regulatory and Data Landscape
A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance...
DTx company leverages Castor’s Real-World Evidence platform in Registry study
How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
Connect with us on LinkedIn
